Boston Scientific

Open: 51.73 Close: 50.62 Change: -1.11

Don't invest in Boston Scientific Company Inc Stock before reading this automated analysis produce by an AI.

This document will help you to evaluate Boston Scientific without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, price, target, analyst, share, last, …

Concept Map

Semantic Network

Stock Summary

Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat.

Today's Summary

Every 21 seconds, a patient is treated with a Boston Scientific product. Jeff Bernstein, Managing Director of Goldman Sachs, will resign from the Board effective August 1, 2023. The consensus analyst rating on Boston Scientific is a Strong Buy.

Today's News

Boston Scientific posted GAAP net income attributable to its common stockholders of $261m or $0.18 earnings per share in Q2 2023, a 6% increase over $246m recorded during the same period last year. Boston Scientific plans to increase production of its Farapulse pulsed-field ablation system. Field Clinical Representative I for Spinal Cord Stimulator  Boston Scientific Neuromodulation. Join a team that is focused on improving the lives of our patients through technology and service. Every 21 seconds, a patient is treated with a Boston Scientific product. Boston Scientific is proud to be an equal opportunity and affirmative action employer. Boston Scientific maintains a drug-free workplace. Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. Jeff Bernstein, Managing Director of Goldman Sachs, will resign from the Board effective August 1, 2023. Raymond James, a well-known investment firm, raised their price target for Boston Scientific shares from $60.00 to $61.00 in a recent research note. 22nd Century Group reaffirmed its “initiates” rating on Boston Scientific. Citigroup raised its target price for. Boston Scientific stock last closed at $50.62 per share, down 2.45%. WallStreetZen was designed to help everyday investors do more accurate fundamental analysis. The consensus analyst rating on Boston Scientific is a Strong Buy. Out of 17 Wall Street analysts who monitor Boston Scientific, their consensus recommendation is to buy. Shani Bird, director of DEI, strives to create a rich tapestry of talent at Boston Scientific. M.I. is the creator of HANOSTENT™ technology. Boston Scientific ( NYSE:BSX – Get Free Report ) last posted its quarterly earnings results on Thursday, July 27th. Boston Scientific had a return on equity of 15.31% and a net margin of 6.81%. Needham analyst Mike Matson maintains Boston Scientific (NYSE: BSX ) with a Buy and raises the price target from $57 to $61. Analyst Price Forecast Suggests 15.85% Upside as of July 6, 2023, the average one-year price target for Boston Scientific is. Boston Scientific recorded a 6.1% bottom-line gain on sales growth of 10.9%. BTIG analysts Marie Thibault and Sam Eiber called the results “outstanding”

Stock Profile

"Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts."

Keywords

Are looking for the most relevant information about Boston Scientific? Investor spend a lot of time searching for information to make investment decisions in Boston Scientific. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, price, target, analyst, share, last, and the most common words in the summary are: boston, scientific, stock, news, share, bsx, net, . One of the sentences in the summary was: The consensus analyst rating on Boston Scientific is a Strong Buy.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #boston #scientific #stock #news #share #bsx #net.